[IF=0] Sondag, Gregory R. OSTEOACTIVIN AND CD44: A NOVEL INTERACTION REGULATING BONE CELL DIFFERENTIATION AND FUNCTION. Diss. Kent State University, 2015. WB ; Mouse.
[IF=5.1] Neal et al. The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor. (2018) J.Neuroinflammation. 15:73 IF(ICC) ; Mouse.
[IF=1.42] Ruan, Wei-Min, et al. "Differential expression of glycoprotein non-metastatic melanoma protein B (GPNMB) involved in trichostatin A-induced apoptosis in gastric cancer." International journal of clinical and experimental medicine 7.12 (2014): 4857-4866. IHSLCP ; Human.
[IF=4.183] Zhu Y et al. Protein Expression Profile in Rat Silicosis Model Reveals Upregulation of PTPN2 and Its Inhibitory Effect on Epithelial-Mesenchymal Transition by Dephosphorylation of STAT3. Int J Mol Sci. 2020 Feb 11;21(4). WB ; Rat&Mouse.
[IF=5.17] Oyewumi et al. Osteoactivin (GPNMB) ectodomain protein promotes growth and invasive behavior of human lung cancer cells. (2016) Oncotarge. 7:13932-44 IHC ; Human.
[IF=1.72] Frara, Nagat, et al. "Growth and repair factors, osteoactivin, matrix metalloproteinase and heat shock protein 72, increase with resolution of inflammation in musculotendinous tissues in a rat model of repetitive grasping." BMC Musculoskeletal Disorders 17.1 (2016): 1. WB ; Rat.
[IF=3.84] Arosarena, Oneida A., et al. "Osteoactivin Promotes Migration of Oral Squamous Cell Carcinomas." Journal of Cellular Physiology (2016). WB ; Human.
[IF=4.6] Abdelmagid, Samir M., et al. "Mutation in Osteoactivin Promotes RANKL-Mediated Osteoclast Differentiation and Survival, but Inhibits Osteoclast Function." Journal of Biological Chemistry (2015): jbc-M114. WB ; Mouse.